论文部分内容阅读
目的:研讨哮喘患者采用孟鲁司特联合舒利迭治疗的效果。方法:从我院呼吸内科接诊的哮喘病例中随机选出100例为观察对象,按随机抽签法均分为研究组与对照组,两组均首先接受舒利迭治疗,研究组加用孟鲁司特治疗,对比两组治疗效果。结果:研究组临床治疗有效率明显高于对照组,且治疗后,研究组的肺功能相关指标改善情况优于对照组,差异均有统计学意义(p<0.05)。结论:哮喘患者采用孟鲁司特联合舒利迭治疗,可迅速改善患者肺功能,疗效显著。
Objective: To study the effect of montelukast combined with seretide in patients with asthma. Methods: 100 cases of asthma admitted from our hospital were randomly selected as observational subjects, divided randomly into study group and control group according to randomized drawing test. Both groups were treated with sevrithione for the first time. The study group plus Meng Lu Si treatment, the two groups compared the therapeutic effect. Results: The effective rate of clinical treatment in study group was significantly higher than that of control group. After treatment, the improvement of pulmonary function-related indicators in study group was better than that in control group (p <0.05). Conclusion: Asthma patients treated with montelukast and seretide can rapidly improve lung function of patients with significant effect.